Evidence is emerging for a direct role of glucose, independent of changes in insulin, in the regulation of cellular glucose transport and glucose utilization in vivo. In this study we investigate potential cellular and molecular mechanisms for this regulatory effect of glucose by determining how normalization of glycemia without insulin therapy in diabetic rats influences 3-O-methylglucose transport and the expression and translocation of two genetically distinct species of glucose transporters (GTs) in adipose cells. These results are compared with alterations in glucose disposal in vivo measured by euglycemic clamp. In rats rendered diabetic by 90% pancreatectomy, insulin-stimulated glucose transport in adipose cells is decreased 50% in parallel with reduced insulin-mediated glucose disposal in vivo. Levels of adipose/muscle GTs measured by immunoblotting are decreased in adipose cell subcellular membrane fractions, as are the corresponding mRNA levels assessed by Northern blotting of total adipose cell RNA. Normalization of blood glucose in diabetic rats with phlorizin, which impairs renal tubular glucose reabsorption and thus enhances glucose excretion, restores insulin-stimulated glucose transport in adipose cells and insulin-mediated glucose disposal in vivo. Importantly, levels of the adipose/muscle GT protein remain 43% reduced in the low-density microsomes in the basal state and 46% reduced in the plasma membranes in the insulin-stimulated state. Adipose/muscle GT mRNA levels remain approximately 50% depressed. Levels of the HepG2/brain GT protein and mRNA are unaltered by diabetes or phlorizin treatment. Thus, changes in ambient glucose independent of changes in ambient insulin can regulate the glucose transport response to insulin in isolated adipose cells and changes in responsiveness parallel alterations in glucose uptake in vivo. Since this effect can occur without alteration in the expression of the two species of glucose transporters present in adipose cells or in their translocation to the plasma membrane in response to insulin, it may result from changes in GT functional activity.
B B Kahn, G I Shulman, R A DeFronzo, S W Cushman, L Rossetti
Title and authors | Publication | Year |
---|---|---|
SGLT2 inhibitors: Cardio-renal metabolic drugs for the ages
Ralph A. DeFronzo |
Journal of Clinical Investigation | 2024 |
Nephroprotective Properties of Antidiabetic Drugs.
Gerdes C, Müller N, Wolf G, Busch M |
Journal of Clinical Medicine | 2023 |
Impact of Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging—What Do We Know So Far? (A Narrative Review)
Adam CA, Anghel R, Marcu DT, Mitu O, Roca M, Mitu F |
Life Sciences | 2022 |
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review
V Mollace, GM Rosano, SD Anker, AJ Coats, P Seferovic, R Mollace, A Tavernese, M Gliozzi, V Musolino, C Carresi, J Maiuolo, R Macrì, F Bosco, M Chiocchi, F Romeo, M Metra, M Volterrani |
Nutrients | 2021 |
Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review
J Fonseca-Correa, R Correa-Rotter |
Frontiers in Medicine | 2021 |
Diet intake control is indispensable for the gluconeogenic response to sodium–glucose cotransporter 2 inhibition in male mice
E Hashiuchi, H Watanabe, K Kimura, M Matsumoto, H Inoue, Y Inaba |
Journal of Diabetes Investigation | 2020 |
The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection
E Brown, JP Wilding, U Alam, TM Barber, J Karalliedde, DJ Cuthbertson |
Annals of Medicine | 2020 |
Biliopancreatic Diversion Induces Greater Metabolic Improvement Than Roux-en-Y Gastric Bypass
LA Harris, BD Kayser, C Cefalo, L Marini, JD Watrous, J Ding, M Jain, JG McDonald, BM Thompson, E Fabbrini, JC Eagon, BW Patterson, B Mittendorfer, G Mingrone, S Klein |
Cell Metabolism | 2019 |
Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease
T Schumann, J König, C Henke, DM Willmes, SR Bornstein, J Jordan, MF Fromm, AL Birkenfeld, MC Michel |
Pharmacological reviews | 2019 |
Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research
AL Beitelshees, BR Leslie, SI Taylor |
Diabetes | 2019 |
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects with Normal Glucose Tolerance
C Shannon, A Merovci, J Xiong, D Tripathy, F Lorenzo, D McClain, M Abdul-Ghani, L Norton, RA DeFronzo |
Diabetes | 2018 |
Astragalus polysaccharides attenuates TNF-α-induced insulin resistance via suppression of miR-721 and activation of PPAR-γ and PI3K/AKT in 3T3-L1 adipocytes
Bin Ke, Xiao Ke, Xuesi Wan, Yubin Yang, Yingjuan Huang, Jian Qin, Chengheng Hu, Lin Shi |
American journal of translational research | 2017 |
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
RA DeFronzo, L Norton, M Abdul-Ghani |
Nature Reviews Nephrology | 2016 |
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
JH Han, TJ Oh, G Lee, HJ Maeng, DH Lee, KM Kim, SH Choi, HC Jang, HS Lee, KS Park, YB Kim, S Lim |
Diabetologia | 2016 |
The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin
M Kern, N Klöting, M Mark, E Mayoux, T Klein, M Blüher |
Metabolism | 2016 |
Insulin Sensitivity-Enhancing Activity of Phlorizin is Associated with Lipopolysaccharides decrease and Gut Microbiota Changes in obese and type 2 diabetes (db/db) Mice
X Mei, X Zhang, Z Wang, Z Gao, G Liu, H Hu, L Zou, X Li |
Journal of Agricultural and Food Chemistry | 2016 |
Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice
K Ogura, M Ogura, T Shoji, Y Sato, Y Tahara, G Yamano, H Sato, K Sugizaki, N Fujita, H Tatsuoka, R Usui, E Mukai, S Fujimoto, N Inagaki, K Nagashima |
Journal of Agricultural and Food Chemistry | 2016 |
SGLT-2 inhibitors: Their pleiotropic properties
NG Vallianou, E Geladari, CE Kazazis |
Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2016 |
Hypothalamic Neurones Governing Glucose Homeostasis
R Coppari |
Journal of Neuroendocrinology | 2015 |
Renal Sodium-Glucose Cotransporter Inhibition in the Management of Type 2 Diabetes Mellitus
MA Abdul-Ghani, L Norton, RA DeFronzo |
American journal of physiology. Renal physiology | 2015 |
Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor
D Devineni, D Polidori |
Clinical Pharmacokinetics | 2015 |
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats: Ipragliflozin for type 1 diabetes
A Tahara, E Kurosaki, M Yokono, D Yamajuku, R Kihara, Y Hayashizaki, T Takasu, M Imamura, Q Li, H Tomiyama, Y Kobayashi, A Noda, M Sasamata, M Shibasaki |
Journal of Pharmacy and Pharmacology | 2014 |
Using nonrandom two-liquid model for solvent system selection in counter-current chromatography
DB Ren, YH Qin, YH Yun, HM Lu, XQ Chen, YZ Liang |
Journal of Chromatography A | 2014 |
Pathobiology of Human Disease
S Akilesh |
Pathobiology of Human Disease | 2014 |
Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidence
AJ Scheen, N Paquot |
Diabetes & Metabolism | 2014 |
Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport
MA Abdul-Ghani, RA DeFronzo |
Journal of Internal Medicine | 2014 |
Protein O-GlcNAcylation in diabetes and diabetic complications
J Ma, GW Hart |
Expert Review of Proteomics | 2013 |
SGLT2 Inhibition: A Novel Prospective Strategy in Treatment of Diabetes Mellitus
AB Deshmukh, MC Patel, B Mishra |
Renal Failure | 2013 |
Ipragliflozin and other sodium–glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: Preclinical and clinical data
E Kurosaki, H Ogasawara |
Pharmacology & Therapeutics | 2013 |
The Role of the Kidney in Hyperglycemia: A New Therapeutic Target in Type 2 Diabetes Mellitus
D Hinnen |
The Journal of cardiovascular nursing | 2013 |
Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus: SGLT2 Inhibitors in the Treatment of Type 2 Diabetes
P Raskin |
Diabetes/Metabolism Research and Reviews | 2013 |
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
MA Abdul-Ghani, L Norton, RA DeFronzo |
Current Diabetes Reports | 2012 |
SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus: SGLT2 inhibitors in diabetes
M Misra |
Journal of Pharmacy and Pharmacology | 2012 |
Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin^|^ndash;Nicotinamide-Induced Mildly Diabetic Mice
A Tahara, E Kurosaki, M Yokono, D Yamajuku, R Kihara, Y Hayashizaki, T Takasu, M Imamura, L Qun, H Tomiyama, Y Kobayashi, A Noda, M Sasamata, M Shibasaki |
Journal of Pharmacological Sciences | 2012 |
Animal Models in Diabetes Research
HG Joost, H Al-Hasani, A Schürmann |
2012 | |
Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and Mice
M Suzuki, K Honda, M Fukazawa, K Ozawa, H Hagita, T Kawai, M Takeda, T Yata, M Kawai, T Fukuzawa, T Kobayashi, T Sato, Y Kawabe, S Ikeda |
The Journal of pharmacology and experimental therapeutics | 2012 |
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans
JF List, JM Whaley |
Kidney International | 2011 |
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients
RL Dobbins, R O’Connor-Semmes, A Kapur, C Kapitza, G Golor, I Mikoshiba, W Tao, EK Hussey |
Diabetes Obesity and Metabolism | 2011 |
Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus
JE Gerich, A Bastien |
Expert Review of Clinical Pharmacology | 2011 |
Reduction in Reactive Oxygen Species Production by Mitochondria From Elderly Subjects With Normal and Impaired Glucose Tolerance
S Ghosh, R Lertwattanarak, N Lefort, M Molina-Carrion, J Joya-Galeana, BP Bowen, JJ Garduno-Garcia, M Abdul-Ghani, A Richardson, RA DeFronzo, L Mandarino, HV Remmen, N Musi |
Diabetes | 2011 |
A New Approach to Glucose Control in Type 2 Diabetes: The Role of Kidney Sodium-Glucose Co-transporter 2 Inhibition
J Basile |
Postgraduate Medicine | 2011 |
Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
MA Abdul-Ghani, L Norton, RA DeFronzo |
Endocrine reviews | 2011 |
In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes
KH Chun, KD Choi, DH Lee, YS Jung, RR Henry, TP Ciaraldi, YB Kim |
American journal of physiology. Endocrinology and metabolism | 2011 |
Management of Pediatric Obesity and Diabetes
RJ Ferry |
2011 | |
Dapagliflozin for adults with type 2 diabetes mellitus
Raval AD, Chovatiya K, Bhavsar AB, Patel MH |
The Cochrane Database of Systematic Reviews | 2011 |
Rapid Upregulation of Sodium-Glucose Transporter SGLT1 in Response to Intestinal Sweet Taste Stimulation
AT Stearns, A Balakrishnan, DB Rhoads, A Tavakkolizadeh |
Annals of Surgery | 2010 |
Renal glucose transporters: novel targets for hyperglycemia management
A Mather, C Pollock |
Nature Reviews Nephrology | 2010 |
Enhancement of Organ Regeneration in Animal Models by a Stem Cell-Stimulating Plant Mixture
I Kiss, A Tibold, R Halmosi, É Bartha, K Koltai, Z Orsós, L Bujdosó, I Ember |
Journal of Medicinal Food | 2010 |
In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes
KH Chun, KD Choi, DH Lee, Y Jung, RR Henry, TP Ciaraldi, YB Kim |
American journal of physiology. Endocrinology and metabolism | 2010 |
Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM)
HY Liu, SY Cao, T Hong, J Han, Z Liu, W Cao |
The Journal of biological chemistry | 2009 |
Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes – mechanisms and potentials for treatment
A Giaccari, G Sorice, G Muscogiuri |
Nutrition, Metabolism and Cardiovascular Diseases | 2009 |
From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus
H Bays |
Current Medical Research and Opinion | 2009 |
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-Ay mice
K Katsuno, Y Fujimori, Y Ishikawa-Takemura, M Isaji |
European Journal of Pharmacology | 2009 |
Inhibitors of type 2 sodium glucose co-transporters – a new strategy for diabetes treatment
A Bołdys, B Okopień |
Pharmacological Reports | 2009 |
Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport
AT Stearns, A Balakrishnan, A Tavakkolizadeh |
AJP Gastrointestinal and Liver Physiology | 2009 |
Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
S Han, DL Hagan, JR Taylor, L Xin, W Meng, SA Biller, JR Wetterau, WN Washburn, JM Whaley |
2008 | |
Series in Medical Physics and Biomedical Engineering: Physiological Norm and Pathology
T Denisova, L Malinova |
Stem Cell Labeling for Delivery and Tracking Using Noninvasive Imaging | 2008 |
Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus
MA Abdul-Ghani, RA DeFronzo |
Endocrine Practice | 2008 |
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
JF List, V Woo, E Morales, W Tang, FT Fiedorek |
2008 | |
Glucose Toxicity Is Responsible for the Development of Impaired Regulation of Endogenous Glucose Production and Hepatic Glucokinase in Zucker Diabetic Fatty Rats
Y Fujimoto, TP Torres, EP Donahue, M Shiota |
2006 | |
Targeting glycogen synthase kinase-3 in insulin signalling
S Frame, D Zheleva |
Expert Opinion on Therapeutic Targets | 2006 |
Phlorizin: a review
JR Ehrenkranz, NG Lewis, CR Kahn, J Roth |
Diabetes/Metabolism Research and Reviews | 2005 |
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini |
International Textbook of Diabetes Mellitus | 2003 |
N -acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress
CA Haber, TK Lam, Z Yu, N Gupta, T Goh, E Bogdanovic, A Giacca, IG Fantus |
American journal of physiology. Endocrinology and metabolism | 2003 |
Impaired glucose tolerance: do pharmacological therapies correct the underlying metabolic disturbance?
RA Defronzo |
The British Journal of Diabetes & Vascular Disease | 2003 |
Insulin Resistance and Insulin Resistance Syndrome
A Cincotta |
Insulin Resistance and Insulin Resistance Syndrome | 2002 |
Mice Deficient in the Insulin-regulated Membrane Aminopeptidase Show Substantial Decreases in Glucose Transporter GLUT4 Levels but Maintain Normal Glucose Homeostasis
SR Keller, AC Davis, KB Clairmont |
The Journal of biological chemistry | 2002 |
Regulation of IRS-2 tyrosine phosphorylation in fasting and diabetes
FA Rojas, AE Hirata, MJ Saad |
Molecular and Cellular Endocrinology | 2001 |
Nuevos tratamientos en la diabetes mellitus
EF Nogueras |
Endocrinología y Nutrición | 2001 |
Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose--potential implications for insulin resistance
Z W Yu, J Burén, S Enerbäck, E Nilsson, L Samuelsson, J W Eriksson |
Biochimica et Biophysica Acta | 2001 |
Effects of cellular ATP depletion on glucose transport and insulin signaling in 3T3-L1 adipocytes
J Kang, E Heart, CK Sung |
American journal of physiology. Endocrinology and metabolism | 2001 |
Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle
A Oku, M Nawano, K Ueta, T Fujita, I Umebayashi, K Arakawa, T Kano-Ishihara, A Saito, M Anai, M Funaki, M Kikuchi, Y Oka, T Asano |
American journal of physiology. Endocrinology and metabolism | 2001 |
Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis
P Iozzo, T Pratipanawatr, H Pijl, C Vogt, V Kumar, R Pipek, M Matsuda, LJ Mandarino, KJ Cusi, RA DeFronzo |
American journal of physiology. Endocrinology and metabolism | 2001 |
Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent?
MC Cam, RW Brownsey, JH McNeill |
Canadian Journal of Physiology and Pharmacology | 2000 |
Innovation im Pflanzenschutz: Trends in der Forschung
J Stetter, F Lieb |
Angewandte Chemie | 2000 |
Glucosamine-induced insulin resistance in 3T3-L1 adipocytes
E Heart, WS Choi, CK Sung |
American journal of physiology. Endocrinology and metabolism | 2000 |
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle
L Rossetti, AE Stenbit, W Chen, M Hu, N Barzilai, EB Katz, MJ Charron |
Journal of Clinical Investigation | 1999 |
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle
L Rossetti, AE Stenbit, W Chen, M Hu, N Barzilai, EB Katz, MJ Charron |
Diabetes | 1999 |
Localization and quantification of glucose transporters in liver of growth-retarded fetal and neonatal rats
RH Lane, SE Crawford, AS Flozak, RA Simmons |
American journal of physiology. Endocrinology and metabolism | 1999 |
Glucosamine Regulation of Glucose Metabolism in Cultured Human Skeletal Muscle Cells: Divergent Effects on Glucose Transport/Phosphorylation and Glycogen Synthase in Non-Diabetic and Type 2 Diabetic Subjects1
TP Ciaraldi, L Carter, S Nikoulina, S Mudaliar, DA McClain, RR Henry |
Endocrinology | 1999 |
Glucose Rapidly Decreases Plasma Membrane GLUT4 Content in Rat Skeletal Muscle
A Marette, D Dimitrakoudis, Q Shi, CD Rodgers, A Klip, M Vranic |
Endocrine | 1999 |
Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
BB Kahn |
Journal of Clinical Investigation | 1998 |
Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
BB Kahn |
Metabolism | 1998 |
Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
BB Kahn |
Metabolism | 1998 |
Mechanisms of Insulin-Resistant Glucose Utilization in Rat Skeletal Muscle
NM Rizk, DA Meier, GR Krakower, AH Kissebah |
Molecular Genetics and Metabolism | 1998 |
Skeletal Muscle Metabolism in Exercise and Diabetes
EA Richter, B Kiens, H Galbo, B Saltin |
1998 | |
Clinical islet cell transplantation: Are we there yet?
L Rosenberg |
International Journal of Gastrointestinal Cancer | 1998 |
Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long–Evans Tokushima Fatty strain
K Toide |
Diabetes Research and Clinical Practice | 1997 |
Insulin resistance in non-obese, non—insulin-dependent diabetic patients with diabetic nephropathy
M Emoto, Y Nishizawa, K Maekawa, T Kawagishi, K Kogawa, Y Hiura, K Mori, S Tanaka, E Ishimura, M Inaba, Y Okuno, H Morii |
Metabolism | 1997 |
Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis
RV Considine, MR Nyce, LE Allen, LM Morales, S Triester, J Serrano, J Colberg, S Lanza-Jacoby, JF Caro |
Journal of Clinical Investigation | 1996 |
Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis
RV Considine, MR Nyce, LE Allen, LM Morales, S Triester, J Serrano, J Colberg, S Lanza-Jacoby, JF Caro |
Journal of Endocrinology | 1996 |
In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution
L Coderre, GA Vallega, PF Pilch, SR Chipkin |
American journal of physiology. Endocrinology and metabolism | 1996 |
In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats
L Rossetti, M Hawkins, W Chen, J Gindi, N Barzilai |
Journal of Clinical Investigation | 1995 |
Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity
AD Baron, JS Zhu, JH Zhu, H Weldon, L Maianu, WT Garvey |
Journal of Clinical Investigation | 1995 |
Palmitoylation of the glucose transporter in blood-brain barrier capillaries
J F Pouliot, R Béliveau |
Biochimica et Biophysica Acta | 1995 |
Facilitative glucose transporters
M MUECKLER |
European Journal of Biochemistry | 1994 |
Subcellular localization and trafficking of the GLUT4 glucose transporter isoform in insulin-responsive cells
GD Holman, SW Cushman |
BioEssays | 1994 |
Pancreas and islet transplantation: An update
DE Sutherland, RW Gruessner, PF Gores |
Transplantation Reviews | 1994 |
Diabetes can be prevented by reducing insulin production
JE Sprietsma, GE Schuitemaker |
Medical Hypotheses | 1994 |
Impaired glucose transport in skeletal muscle but normal GLUT-4 tissue distribution in glucose-infused rats
MB Davidson, C Bouch, N Venkatesan, RG Karjala |
American journal of physiology. Endocrinology and metabolism | 1994 |
Persistence of disturbed adipocyte metabolism in sterptozocin-induced diabetic rats despite near-euglycemia with phlorizin
GJ Mick, K Hingre, M Benedict, KL McCormick |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 1994 |
Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man
SD Prato, F Leonetti, DC Simonson, P Sheehan, M Matsuda, RA DeFronzo |
Diabetologia | 1994 |
Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance
JR Zierath, D Galuska, LA Nolte, A Thrne, JS Kristensen, H Wallberg-Henriksson |
Diabetologia | 1994 |
The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat
CJ Nolan, J Proietto |
Diabetologia | 1994 |
EJB Reviews 1994
P Christen, E Hofmann |
1994 | |
Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene
JL Treadway, DM Hargrove, NA Nardone, RK McPherson, JF Russo, AJ Milici, HA Stukenbrok, EM Gibbs, RW Stevenson, JE Pessin |
The Journal of biological chemistry | 1994 |
The Effect of Intensive Insulin Therapy on the Insulin-regulatable Glucose Transporter (GLUT4) Expression in Skeletal Muscle in Type 1 Diabetes
PH Andersen, H Vestergaard, S Lund, P Vedel, S Junker, BB Kahn, O Pedersen |
Diabetic Medicine | 1993 |
Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control
ML Liu, EM Gibbs, SC McCoid, AJ Milici, HA Stukenbrok, RK McPherson, JL Treadway, JE Pessin |
Proceedings of the National Academy of Sciences | 1993 |
Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins
SA Baldwin |
Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes | 1993 |
1 Cellular insulin action and insulin resistance
WT Garvey, MJ Birnbaum |
Baillière's Clinical Endocrinology and Metabolism | 1993 |
Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes
D Rosenbaum, RS Haber, A Dunaif |
American journal of physiology. Endocrinology and metabolism | 1993 |
Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism
SM Brichard, JC Henquin, J Girard |
Diabetologia | 1993 |
Regulation of the GLUT4/muscle-fat glucose transporter mRNA in adipose tissue of insulin-deficient diabetic rats
PM Gerrits, AL Olson, JE Pessin |
The Journal of biological chemistry | 1993 |
Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. Evidence that exocytosis is a critical site of hormone action
S Satoh, H Nishimura, AE Clark, IJ Kozka, SJ Vannucci, IA Simpson, MJ Quon, SW Cushman, GD Holman |
The Journal of biological chemistry | 1993 |
Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors
ER Seaquist, RP Robertson |
Journal of Clinical Investigation | 1992 |
Effect of streptozotocin-induced diabetes on GLUT-4 phosphorylation in rat adipocytes
N Begum, B Draznin |
Journal of Clinical Investigation | 1992 |
Treatment of diabetes mellitus
RP Robertson, DJ Klein |
Diabetologia | 1992 |
Alterations in glucose transporter expression and function in diabetes: Mechanisms for insulin resistance
BB Kahn |
Journal of Cellular Biochemistry | 1992 |
Acute and chronic signals controlling glucose transport in skeletal muscle
A Klip, A Marette |
Journal of Cellular Biochemistry | 1992 |
Insulin resistance in Type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle
J Eriksson, L Koranyi, R Bourey, C Schalin-Jntti, E Widn, M Mueckler, AM Permutt, LC Groop |
Diabetologia | 1992 |
Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats
BB Kahn, L Rossetti, HF Lodish, MJ Charron |
Journal of Clinical Investigation | 1991 |
Insulin Resistance — Mechanisms, Syndromes, and Implications
FH Epstein, DE Moller, JS Flier |
New England Journal of Medicine | 1991 |
International Review of Cytology
RA Miller |
International Review of Cytology | 1991 |
Proceedings of the 1990 Laurentian Hormone Conference
AE Boyd, L Aguilar-Bryan, J Bryan, DL Kunze, L Moss, DA Nelson, AS Rajan, H Raef, H Xiang, GC Yaney |
Proceedings of the 1990 Laurentian Hormone Conference | 1991 |
Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha
JM Stephens, PH Pekala |
The Journal of biological chemistry | 1991 |